Amicogen, Inc. (KOSDAQ:092040)
South Korea · Delayed Price · Currency is KRW 1,880.00
+77.00 (4.27%)
May 20, 2026, 3:30 PM KST
Amicogen Market Cap
Amicogen has a market cap or net worth of 132.45 billion as of May 20, 2026. Its market cap has decreased by -28.62% in one year.
Market Cap
132.45B
Enterprise Value
231.29B
Revenue
41.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,880.00
Market Cap Chart
Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 132.45B, a decrease of -44.16%. That is a compound annual growth rate of -4.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 127.03B | 28.37% |
| Dec 30, 2025 | 98.95B | -53.23% |
| Dec 30, 2024 | 211.59B | -48.65% |
| Dec 28, 2023 | 412.06B | 8.63% |
| Dec 29, 2022 | 379.32B | -38.89% |
| Dec 30, 2021 | 620.70B | -14.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JETEMA, | 209.12B |
| Genexine | 186.47B |
| Macrogen | 151.78B |
| MedPacto | 141.38B |
| Vaxcell-Bio Therapeutics | 137.68B |
| ENCell | 126.08B |
| GeneOne Life Science | 123.86B |
| iNtRON Biotechnology | 97.05B |